Wolverine Trading, LLC Atea Pharmaceuticals, Inc. Transaction History

Wolverine Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.09 - $4.56 $22,523 - $33,237	7,289 Added 52.54%	21,163 $85,000
Q4 2023 Feb 14, 2024	BUY	$2.8 - $3.35 $38,847 - $46,477	13,874 New	13,874 $42,000
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $61,225 - $93,963	-11,487 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.5 - $9.19 $63,178 - $105,565	11,487 New	11,487 $81,000

112

52.4M

900

126K

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $270M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.